An Innovative Glycan and Glycopeptide MSn Data Analysis Tool
SimGlycan® predicts the structure of glycans and glycopeptides using mass spectrometry data. SimGlycan® accepts the experimental MS/MS and Multi Stage/Sequential mass spectrometry (MSn, n>2) data, matches them with its own database of theoretical fragments and generates a list of probable candidate structures. Each structure is scored to reflect how closely it matches your experimental data. Apart from the structural information, other biological information for the probable molecular structures such as the glycan class (N-Linked, O-Linked heparin, lipopolysaccharide etc.), reaction, pathway and enzyme are also made available for easy reference in
case of structural elucidation of glycans while in the case of glycopeptide qualitative analysis, information such
as Protein ID, Protein Name, Source, Classification, Class, peptide sequence, peptide mass etc. are made
available for identified glycopeptides.
These experimental mass spectrometry data can be uploaded in SimGlycan® using standard file formats or
directly from mass spectrometer raw files from AB SCIEX (TripleTOF™ 5600 System, TOF/TOF 5800, 4800 Plus
MALDI TOF/TOF™ Analyzer, QTRAP® 6500 System, 4000 QTRAP® and QSTAR® Elite Systems, 4000 QTRAP® and QSTAR® Elite
Systems), Agilent Technologies (Agilent 6200 Series TOF LC/MS and Agilent 6500 Series Q-TOF LC/MS
systems), Bruker Corporation (ultrafleXtreme™ MALDI TOF/TOF, ultraflex™ MALDI TOF/TOF, autoflex™ TOF
and TOF/TOF, maXis™ UHR-TOF, micrOTOF™, micrOTOF-Q™, solariX™ Qq-FTMS, and amaZon™ ion trap
series), Thermo Scientific™ (LTQ FT Ultra, LTQ Velos, LTQ XL, LTQ Orbitrap Discovery, LTQ Orbitrap Velos,
LTQ Orbitrap XL, MALDI LTQ Orbitrap, Orbitrap Elite, Q Exactive, Thermo Scientific™ Orbitrap™ Fusion™
Tribrid mass spectrometer and Thermo Scientific™ Q Exactive™ hybrid quadrupole-Orbitrap mass spectrometer) and Waters Corporation (SYNAPT G2 HDMS, SYNAPT G2 MS, Xevo G2 QTof, Xevo QTof MS, Xevo TQ MS and Xevo TQ-S platforms).
For supporting automated data analysis of different instrument workflows, SimGlycan® includes comprehensive
support for different adducts such as H, Li, Na, Mg2+, K, HCOO- and NH4+ and adduct combinations such as Na +
H, Li + H etc. MS/MS fragmentation patterns of glycans and glycopeptides (based on different instrument
settings) can be specified in order to enable the program to reduce false positives from the data analysis results.
SimGlycan® can analyze mass spectrometry data for released glycans that are underivatized, permethylated and
reducing end modified. It also provides comprehensive support to perform MSn data analysis, which assists in
resolving heterogeneity, branching patterns and isobaric oligosaccharide structures. SimGlycan® can identify
complex glycosaminoglycan structures even when some of the carbohydrate residues are modified with
substituents such as sulfate, phosphate, ethanolamine etc.
SimGlycan® also includes comprehensive support for resolving glycopeptides obtained from a LC-MS/MS run of
proteolytically digested purified glycoproteins. The Protein ID, Protein sequence or peptide sequences identified
by a third party tool will be used as initial input in SimGlycan® in order to identify the glycopeptides from data
dependent MS/MS data. SimGlycan® identifies probable glycan-peptide combinations and ranks them on the
basis of observed peaks corresponding to diagnostic ions.
Glycan & Glycopeptide MS/MS Data Analysis for Studying Glycosylation
Protein Glycosylation, which is a key post-translational modification, is the result of addition of a glycan to a
peptide sequence. Glycopeptides are known to exhibit multiple biological functions. In order to identify distinct
functional properties for defined structural features, detailed information on the respective glycan moieties is
essential. In order to understand all these phenomena, glycosylation analysis is an area of growing interest.
Glycans have also been found to participate in many biological processes including embryonic development,
inter and intracellular activities, coordination of immune functions, pathogens homing on their host tissues, cell
division processes and protein regulations and interactions.
Glycoprotein glycosylation analysis has since long been a challenging task for biochemists. SimGlycan® assists
in predicting the structure of a glycan from the released glycan MS/MS data or directly a glycopeptide (peptide
chain modified with a single or two glycan structures) from glycopeptide MS/MS data acquired using various
ionization techniques of mass spectrometry. Besides, it supports MS/MS data for released glycans with different
chemical derivatives such as permethylation and various reducing terminal modifications. The facility to specify a
user defined reducing end mass for permethylated glycans is also available. All these features facilitate accurate
study of protein glycosylation providing a strong base for developing a sensitive analytic approach to achieve
complete quality analysis of glycoprotein therapeutics.